BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32751570)

  • 1. Safety and Use of MLC601/MLC901 (NeuroAiD
    Kumar R; Abu Bakar A; Thanabalan J; Paramasvaran S; Toh CJ; Jaffar A; Fadzil F; Kamalanathan P; Soon BH; Venketasubramanian N
    Brain Sci; 2020 Jul; 10(8):. PubMed ID: 32751570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The NeuroAiD Safe Treatment (NeST) Registry: a protocol.
    Venketasubramanian N; Kumar R; Soertidewi L; Abu Bakar A; Laik C; Gan R
    BMJ Open; 2015 Nov; 5(11):e009866. PubMed ID: 26567259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Factors and Pattern of Long-Term Recovery with MLC601 (NeuroAiD™) in the Chinese Medicine NeuroAiD Efficacy on Stroke Recovery - Extension Study.
    Venketasubramanian N; Lee CF; Young SH; Tay SS; Umapathi T; Lao AY; Gan HH; Baroque Ii AC; Navarro JC; Chang HM; Advincula JM; Muengtaweepongsa S; Chan BP; Chua CL; Wijekoon N; de Silva HA; Hiyadan JH; Suwanwela NC; Wong KS; Poungvarin N; Eow GB; Chen CL;
    Cerebrovasc Dis; 2017; 43(1-2):36-42. PubMed ID: 27846631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spinal Cord Injury-Assessing Tolerability and Use of Combined Rehabilitation and NeuroAiD (SATURN Study): Protocol of An Exploratory Study In Assessing the Safety and Efficacy of NeuroAiD Amongst People Who Sustain Severe Spinal Cord Injury.
    Kumar R; Htwe O; Baharudin A; Ariffin MH; Abdul Rhani S; Ibrahim K; Rustam A; Gan R
    JMIR Res Protoc; 2016 Dec; 5(4):e230. PubMed ID: 27919862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency and Clinical Impact of Serious Adverse Events on Post-Stroke Recovery with NeuroAiD (MLC601) versus Placebo: The CHInese Medicine Neuroaid Efficacy on Stroke Recovery Study.
    Venketasubramanian N; Moorakonda RB; Lu Q; Chen CLH;
    Cerebrovasc Dis; 2020; 49(2):192-199. PubMed ID: 32126551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Durability of the beneficial effect of MLC601 (NeuroAiD™) on functional recovery among stroke patients from the Philippines in the CHIMES and CHIMES-E studies.
    Navarro JC; Chen CL; Lee CF; Gan HH; Lao AY; Baroque AC; Hiyadan JH; Chua CL; San Jose MC; Advincula JM; Venketasubramanian N;
    Int J Stroke; 2017 Apr; 12(3):285-291. PubMed ID: 27784824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The
    Chen CLH; Sharma PR; Tan BY; Low C; Venketasubramanian N
    Alzheimers Dement (N Y); 2019; 5():38-45. PubMed ID: 30723778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of MLC901 in cerebral venous sinus thrombosis: Three case reports.
    Arsovska AA; Venketasubramanian N
    World J Clin Cases; 2024 Jan; 12(2):346-353. PubMed ID: 38313657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MLC901 (NeuroAiD II™) for cognition after traumatic brain injury: a pilot randomized clinical trial.
    Theadom A; Barker-Collo S; Jones KM; Parmar P; Bhattacharjee R; Feigin VL
    Eur J Neurol; 2018 Aug; 25(8):1055-e82. PubMed ID: 29611892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chinese medicine NeuroAiD efficacy stroke recovery-extension study (CHIMES-E study): an observational multicenter study to investigate the longer-term efficacy of NeuroAiD in stroke recovery.
    Venketasubramanian N; Young S; Tay SS; Chang HM; Umapathi T; Chan B; de Silva A; Wong L; Navarro J; Zhao YD; Tan SB; Chen C
    Cerebrovasc Dis; 2013; 35 Suppl 1():18-22. PubMed ID: 23548915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Long-term Study of NeuroAid (MLC601, MLC901) in Patients with Alzheimer's Disease; An Extension 8-year Follow-up Study.
    Pakdaman H; Amini Harandi A; Gharagozli K; Siavoshi F; Shirzadeh Barough S; Sharifipour E; Esfandani A; Ilkhani S; Tabatabaei FS; Sobhanian SA
    Curr Aging Sci; 2023; 16(3):234-239. PubMed ID: 36843256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NeuroAid II (MLC901) in Haemorrhagic Stroke.
    Tan CN; Choy D; Venketasubramanian N
    Case Rep Neurol; 2020; 12(Suppl 1):212-217. PubMed ID: 33505298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Combined Treatment with MLC601 (NeuroAiDTM) and Rehabilitation on Post-Stroke Recovery: The CHIMES and CHIMES-E Studies.
    Suwanwela NC; Chen CLH; Lee CF; Young SH; Tay SS; Umapathi T; Lao AY; Gan HH; Baroque Ii AC; Navarro JC; Chang HM; Advincula JM; Muengtaweepongsa S; Chan BPL; Chua CL; Wijekoon N; de Silva HA; Hiyadan JHB; Wong KSL; Poungvarin N; Eow GB; Venketasubramanian N;
    Cerebrovasc Dis; 2018; 46(1-2):82-88. PubMed ID: 30184553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ischemic Stroke and Savings in Time to Achieve Functional Recovery: Experience from NeuroAiD.
    Venketasubramanian N; Pokharkar Y; Chai JH; Chen CLH
    J Cardiovasc Dev Dis; 2023 Mar; 10(3):. PubMed ID: 36975881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of patient selection in demonstrating treatment effect in stroke recovery trials: lessons from the CHIMES study of MLC601 (NeuroAiD).
    Venketasubramanian N; Lee CF; Wong KS; Chen CL
    J Evid Based Med; 2015 Aug; 8(3):149-53. PubMed ID: 26291445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Use of NeuroAiD (MLC601) in Postischemic Stroke Patients.
    Navarro JC; Molina MC; Baroque Ii AC; Lokin JK
    Rehabil Res Pract; 2012; 2012():506387. PubMed ID: 23304514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety profile of MLC601 (Neuroaid) in acute ischemic stroke patients: A Singaporean substudy of the Chinese medicine neuroaid efficacy on stroke recovery study.
    Young SH; Zhao Y; Koh A; Singh R; Chan BP; Chang HM; Venketasubramanian N; Chen C;
    Cerebrovasc Dis; 2010; 30(1):1-6. PubMed ID: 20395679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective and neuroproliferative activities of NeuroAid (MLC601, MLC901), a Chinese medicine, in vitro and in vivo.
    Heurteaux C; Gandin C; Borsotto M; Widmann C; Brau F; Lhuillier M; Onteniente B; Lazdunski M
    Neuropharmacology; 2010 Jun; 58(7):987-1001. PubMed ID: 20064536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CHInese Medicine NeuroAiD Efficacy on Stroke Recovery - Extension Study (CHIMES-E): A Multicenter Study of Long-Term Efficacy.
    Venketasubramanian N; Young SH; Tay SS; Umapathi T; Lao AY; Gan HH; Baroque AC; Navarro JC; Chang HM; Advincula JM; Muengtaweepongsa S; Chan BP; Chua CL; Wijekoon N; de Silva HA; Hiyadan JH; Suwanwela NC; Wong KS; Poungvarin N; Eow GB; Lee CF; Chen CL;
    Cerebrovasc Dis; 2015; 39(5-6):309-18. PubMed ID: 25925713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between Baseline NIHSS Limb Motor Score and Functional Recovery after Stroke: Analysis Based on a Multicountry Dataset.
    Chen CLH; Pokharkar Y; Venketasubramanian N;
    Cerebrovasc Dis; 2023; 52(2):160-165. PubMed ID: 35908546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.